WHO/FDA registered Antimalarial, Pyramax approved for coronavirus clinical trials ghanavisions.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ghanavisions.com Daily Mail and Mail on Sunday newspapers.
Pyramax is also being tried in South Africa, Kenya and Burkina Faso to pick African efficacy data
The World Health Organisation prequalified and Ghana Food and Drugs Authority registered Antimalarial Pyramax (Artesunate-Pyronaridine), a fixed-dose combination medication for the treatment of malaria, has been approved for clinical trials for Covid-19 in South Korea.
Also, it is being tried in South Africa, Kenya and Burkina Faso to pick African efficacy data.
The study, which is being led by the Liverpool School of Hygiene and Tropical Medicine, has the primary purpose to compare and evaluate Pyramax efficacy and safety in treating patients infected with the coronavirus, especially mild to moderate covid-19 infection and viral clearance (negative nasal swab) on Day 7.
For Ghana news, breaking news headlines and today s news in Ghana, logon to Graphic Online news website to stay on top of Ghana s biggest stories by Daily Graphic Newspaper.